首頁 › 重度憂鬱症 › 賓夕法尼亞州 › Philadelphia
Philadelphia, PA 的 重度憂鬱症 臨床試驗
23 項針對 重度憂鬱症 的研究正在 Philadelphia（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
招募中3 期
- Adams Clinical Philadelphia, Philadelphia
- Flourish Research Philadelphia, Philadelphia
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
招募中3 期
- Adams Clinical Philadelphia, Philadelphia
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
招募中3 期
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester · 距離 24 英里
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
招募中3 期
- Adams Clinical Philadelphia, Philadelphia
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester · 距離 24 英里
Precision Depression Adalimumab Trial
招募中2 期
- University of Pennsylvania, Philadelphia
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
招募中3 期
- University of Pennsylvania - Perelman School of Medicine, Philadelphia
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
招募中3 期
- University of Pennsylvania, Philadelphia
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
招募中早期第 1 期
- University of Pennsylvania, Philadelphia
Decoding and Modulating Affective Brain States
招募中提及參與者補貼
- University of Pennsylvania, Philadelphia
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
招募中2 期
- Draig Clinical Site, Media · 距離 12 英里
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
招募中
- Pennsylvania Hospital, Philadelphia
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
招募中2 期
- Draig Clinical Site, Media · 距離 12 英里
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
招募中3 期
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Philadelphia
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Adams Clinical - Philadelphia, Philadelphia
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
招募中2 期
- Adams Clinical, Philadelphia
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Philadelphia
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Philadelphia
Triage Survey for Psychiatry Research Eligibility
招募中觀察性研究
- Adams Clinical, Philadelphia, Philadelphia
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
招募中2 期
- University of Pennsylvania, Philadelphia
Taking Action for College Students
招募中
- Temple University, Philadelphia
Neurofeedback to Treat Depression - 2
招募中
- Center for Neuromodulation in Depression and Stress, Philadelphia
Study of ALTO-300 in MDD
招募中2 期
- Site 350, Media · 距離 12 英里
其他城市的 重度憂鬱症 試驗
- New York City, NY36 項研究
- Boston, MA31 項研究
- Atlanta, GA25 項研究
- Orlando, FL19 項研究
- Miami, FL18 項研究
- Chicago, IL17 項研究
- Tampa, FL17 項研究
- Houston, TX16 項研究
- San Diego, CA16 項研究
- Little Rock, AR14 項研究
- Austin, TX13 項研究
- Las Vegas, NV13 項研究
Philadelphia 的其他研究
- 癌症（所有類型）59 項研究
- 乳癌56 項研究
- 非小細胞肺癌51 項研究
- 轉移性癌症46 項研究
- 前列腺癌44 項研究
- 大腸直腸癌44 項研究
- 卵巢癌44 項研究
- 肺癌36 項研究
- 急性髓系白血病34 項研究
- 心臟衰竭31 項研究
- 子宮內膜癌28 項研究
- 憂鬱症26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。